Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research

Author： Wolf Armin   Kampik Anselm  

Publisher： Springer Publishing Company

ISSN： 0721-832X

Source： Graefe's Archive for Clinical and Experimental Ophthalmology, Vol.252, Iss.4, 2014-04, pp. : 647-655

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration

By Gamulescu Maria-Andreea   Radeck Viola   Lustinger Bruno   Fink Bianca   Helbig Horst  

International Ophthalmology, Vol. 30, Iss. 3, 2010-06 ,pp. : 261-266

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of age-related macular degeneration

By Stokkermans T.J.W.  

Clinical Eye and Vision Care, Vol. 12, Iss. 1, 2000-03 ,pp. : 15-35

Elsevier

Access to resources Recommend Favorite

Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration - twelve-month clinical outcomes

By The Anecortave Acetate Clinical Study Group  

Ophthalmology, Vol. 110, Iss. 12, 2003-12 ,pp. : 2372-2383

Elsevier

Access to resources Recommend Favorite

Prevention of age-related macular degeneration

By Wong Ian  

International Ophthalmology, Vol. 31, Iss. 1, 2011-02 ,pp. : 73-82

Springer Publishing Company

Access to resources Recommend Favorite

Optical coherence tomography-based intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

By Ernst Benjamin   Barkmeier Andrew   Akduman Levent  

International Ophthalmology, Vol. 30, Iss. 3, 2010-06 ,pp. : 267-270

Springer Publishing Company

Access to resources Recommend Favorite